Kim SI - Search Results

1

Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.

Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ. Baek SY, et al. Among authors: kim hj, kim si, kim sy, kim s, kim ls, kim ha. J Clin Oncol. 2023 Nov 1;41(31):4864-4871. doi: 10.1200/JCO.23.00557. Epub 2023 Aug 22. J Clin Oncol. 2023. PMID: 37607321 Clinical Trial.

2

Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.

Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W; Korean Breast Cancer Society. Ahn SH, et al. Among authors: kim sw, kim si. J Clin Oncol. 2007 Jun 10;25(17):2360-8. doi: 10.1200/JCO.2006.10.3754. Epub 2007 May 21. J Clin Oncol. 2007. PMID: 17515570

3

Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: biannual update.

Ko SS; Korean Breast Cancer Society. Ko SS, et al. J Surg Oncol. 2008 Oct 1;98(5):318-23. doi: 10.1002/jso.21110. J Surg Oncol. 2008. PMID: 18623175

4

Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Kim SI, Sohn J, Koo JS, Park SH, Park HS, Park BW. Kim SI, et al. Oncology. 2010;79(5-6):324-30. doi: 10.1159/000322192. Epub 2011 Mar 23. Oncology. 2010. PMID: 21430399 Free article.

5

Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR).

Kim J, Lim W, Kim EK, Kim MK, Paik NS, Jeong SS, Yoon JH, Park CH, Ahn SH, Kim LS, Han S, Nam SJ, Kang HS, Kim SI, Yoo YB, Jeong J, Kim TH, Kang T, Kim SW, Jung Y, Lee JE, Kim KS, Yu JH, Chae BJ, Jung SY, Kang E, Choi SY, Moon HG, Noh DY, Han W. Kim J, et al. Among authors: kim th, kim sw, kim ek, kim si, kim ls, kim ks, kim mk. BMC Cancer. 2014 Mar 10;14:170. doi: 10.1186/1471-2407-14-170. BMC Cancer. 2014. PMID: 24612502 Free PMC article. Clinical Trial.

6

Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication.

Kim MH, Lee S, Koo JS, Jung KH, Park IH, Jeong J, Kim SI, Park S, Park HS, Park BW, Kim JH, Sohn J. Kim MH, et al. Among authors: kim si, kim jh. PLoS One. 2015 Mar 24;10(3):e0120320. doi: 10.1371/journal.pone.0120320. eCollection 2015. PLoS One. 2015. PMID: 25803816 Free PMC article.

7

Local control of brain metastasis: treatment outcome of focal brain treatments in relation to subtypes.

Chong JU, Ahn SG, Lee HM, Park JT, Lee SA, Park S, Jeong J, Kim SI. Chong JU, et al. Among authors: kim si. J Breast Cancer. 2015 Mar;18(1):29-35. doi: 10.4048/jbc.2015.18.1.29. Epub 2015 Mar 27. J Breast Cancer. 2015. PMID: 25834608 Free PMC article.

8

Poor Prognosis of Lower Inner Quadrant in Lymph Node-negative Breast Cancer Patients Who Received No Chemotherapy: A Study Based on Nationwide Korean Breast Cancer Registry Database.

Hwang KT, Kim J, Kim EK, Jung SH, Sohn G, Kim SI, Jeong J, Lee HJ, Park JH, Oh S; Korean Breast Cancer Society. Hwang KT, et al. Among authors: kim ek, kim si, kim j. Clin Breast Cancer. 2017 Jul;17(4):e169-e184. doi: 10.1016/j.clbc.2016.12.011. Epub 2017 Jan 10. Clin Breast Cancer. 2017. PMID: 28169145

9

Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.

Ahn SG, Lee JH, Lee HW, Jeon TJ, Ryu YH, Kim KM, Sohn J, Yun M, Lee SA, Jeong J, Kim SI. Ahn SG, et al. Among authors: kim km, kim si. PLoS One. 2017 Apr 18;12(4):e0175048. doi: 10.1371/journal.pone.0175048. eCollection 2017. PLoS One. 2017. PMID: 28419166 Free PMC article.

10

Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.

Choi SH, Kim JW, Choi J, Sohn J, Kim SI, Park S, Park HS, Jeong J, Suh CO, Keum KC, Kim YB, Lee IJ. Choi SH, et al. Among authors: kim si, kim yb, kim jw. Clin Breast Cancer. 2018 Apr;18(2):e167-e178. doi: 10.1016/j.clbc.2017.06.002. Epub 2017 Jun 17. Clin Breast Cancer. 2018. PMID: 28689012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,415 results

Search Page